As part of SMi's leading Injectable conference series, we will assess digital health and connected devices, biologics, biosimilars and biocompatibility for drug device combination products, platform and device selection, regulatory insights and explore the West Coast's biotech innovators.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Device Testing Managers, Senior Device Engineers, Heads of Device Development, Heads of Formulation and Drug Process Development, and many more.
Plus, a workshop on human factors and risk management:
Benefits of attending:
Chairs for 2020:
• Shannon Clark, Principal, UserWise
• Steven Badelt, Founder and Managing Partner, Suttons Creek, Inc.
Featured 2020 speakers include:
• Kristina Lauritsen, Combination Products Regulatory Advisor, FDA/CDER
• Manuela Gazzard, Group Executive Director Regulatory Services Healthcare, BSI
• Christine Lynn Lanning, Distinguished Scientist, Device Area Leader, Safety Assessment/Merck & Co., Inc
• Khaudeja Bano, Senior Medical Director, Abbott Laboratories
• Jace Blackburn, Smart Device Engineer, Genentech
• Michael Koby, Senior Principle Scientist, Pfi zer
• James Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals
• Walter Goodwin, Device Engineer, Device Development & Clinical Packaging Engineering, Gilead Sciences
• Katie Atkinson, Manager Human Factors Engineering, Bigfoot Biomedical
EARLY-BIRD RATES:
Additional Contact Info:
T: +44 (0)20 7827 6088
E: hsidhu@
LinkedIn: @SMi Pharma Twitter: #smipfsusa
14 Sep 2020 @ 08:30 am
15 Sep 2020 @ 08:31 am
Duration: 1 days
Hyatt Centric Fisherman's Wharf, San Francisco
555 North Point Street
94133 San Francisco
United States
English en